Published Guidance, NICE advice and quality standards
Showing 1 to 3 of 3
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Everolimus with exemestane for treating advanced breast cancer after endocrine therapy | TA421 | ||
| Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens | TA423 | ||
| Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | TA424 |